<DOC>
	<DOCNO>NCT01760889</DOCNO>
	<brief_summary>The primary purpose study determine whether SPD489 low dose range ( 40 , 80 , 100mg ) high dose range ( 120 , 140 , 160mg ) effective treatment Negative Symptoms .</brief_summary>
	<brief_title>SPD489 Low Dose High Dose Ranges When Added Stable Doses Antipsychotic Medications Clinically Stable Adults With Negative Symptoms Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>18 65 year age Has reliable informant ( eg , family member , social worker , caseworker , nurse spends &gt; 4 hours/week subject ) Fixed home/place residence reach telephone On stable dose antipsychotic medication Able swallow capsule Taking lithium , carbamazepine , lamotrigine , gabapentin , cholinesterase inhibitor , modafinil , stimulant methylphenidate amphetamine product Treated clozapine past 30 day Lifetime history stimulant , cocaine , amphetamine abuse dependence History seizure ( infantile febrile seizure ) , tic disorder , current diagnosis and/or know family history Tourette 's Disorder , serious neurological disease , history significant head trauma , dementia , cerebrovascular disease , Parkinson 's disease , intracranial lesion Uncontrolled hypertension History thyroid disorder stabilize thyroid medication Glaucoma Pregnant nursing Subject receive investigational product participate clinical study within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>